Quell Therapeutics
Latest round
- Series B
Last raised
- Nov 2021
Total raised
- $202M
Investors
- 11
About Quell Therapeutics
Based in London, UK, and founded in 2019, Quell Therapeutics Ltd. provides regulatory T cells (Treg) therapies as immunosuppression for patients recovering from a liver transplant. The company was co-founded by Giovanna Lombardi, Marc Martinez-Llordella, Alberto Sánchez-Fueyo, Hans Stauss, Emma Morris, and Elmar Jaeckel. In 2019 and 2021, Quell Therapeutics Ltd. Quell Therapeutics Ltd. works with pharmaceutical companies, by offering the regulatory T cells (Treg) therapies for immune dysregulations, such as autoimmunity, inflammatory conditions, and solid organ transplantation, for patients recovering from a liver transplant. Therapies will enable patients to live with transplanted liver without taking immunosuppressive medication. The company will offer the therapy under the research & preclinical development phase for future commercialization. The company generates revenue by selling the therapies for immunosuppression to pharmaceutical companies.’s future strategy includes further research and preclinical development of immunosuppression therapies and expanding the senior leadership team.
Who invested in Quell Therapeutics
11 investors across 3 rounds
See all investors in Quell Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Quell Therapeutics
Who invested in Quell Therapeutics?
Quell Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Quell Therapeutics raised?
Quell Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Quell Therapeutics last raise money?
Quell Therapeutics's most recent round on record is a Series B, in Nov 2021.
What does Quell Therapeutics do?
Based in London, UK, and founded in 2019, Quell Therapeutics Ltd.
Where is Quell Therapeutics headquartered?
Quell Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Quell Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Quell Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Quell Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.